Distinct contributions of two choline-producing enzymatic activities to lysophosphatidic acid production in human amniotic fluid from pregnant women in the second trimester and after parturition.


Journal

Prostaglandins & other lipid mediators
ISSN: 1098-8823
Titre abrégé: Prostaglandins Other Lipid Mediat
Pays: United States
ID NLM: 9808648

Informations de publication

Date de publication:
10 2020
Historique:
received: 10 12 2019
revised: 22 05 2020
accepted: 11 06 2020
pubmed: 26 6 2020
medline: 1 9 2021
entrez: 26 6 2020
Statut: ppublish

Résumé

The purpose of this study was to clarify whether human amniotic fluid (AF) contains a significant level of bioactive lysophosphatidic acid (LPA) and, whether autotaxin (ATX) is involved in the production of LPA, if present. Using LC-MS/MS, we found a higher ratio of levels of LPA and its precursor lysophosphatidylcholine (LPC) in AF collected after parturition than that in AF collected at the middle stage of pregnancy. We detected significant choline-producing enzymatic activity toward an exogenous LPC in AF at the middle stage of pregnancy, about half of which was ascribable to ATX. In AF collected after parturition, the ATX-independent choline-producing activity of glycerophosphcholine phosphodiesterase coupled to lysophospholipase A activity was increased in relative to the lysophospholipase D activity of ATX. These results suggest that the increased LPA/LPC ratio in AF at the term of pregnancy was due to not only a moderate increase in the level of LPC, but also an unknown mechanism involving epithelial cells bathed with AF.

Identifiants

pubmed: 32585250
pii: S1098-8823(20)30064-2
doi: 10.1016/j.prostaglandins.2020.106471
pii:
doi:

Substances chimiques

Lysophosphatidylcholines 0
Lysophospholipids 0
Phosphoric Diester Hydrolases EC 3.1.4.-
alkylglycerophosphoethanolamine phosphodiesterase EC 3.1.4.39
Choline N91BDP6H0X
lysophosphatidic acid PG6M3969SG

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106471

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Midori Fukui (M)

Department of Pharmaceutical Health Chemistry, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8505, Japan.

Toshihiko Tsutsumi (T)

Faculty of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Nobeoka, 882-8508, Japan.

Aimi Yamamoto-Mikami (A)

Department of Pharmaceutical Health Chemistry, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8505, Japan.

Katsuya Morito (K)

Department of Pharmaceutical Health Chemistry, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8505, Japan.
Department of Pharmaceutical Health Chemistry, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8505, Japan.

Tamotsu Tanaka (T)

Department of Pharmaceutical Health Chemistry, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8505, Japan; Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima 770-8513, Japan.

Takeshi Iwasa (T)

Department of Obstetrics and Gynecology, Institute of Health Biosciences, University of Tokushima School of Medicine, Tokushima 770-8503, Japan.

Akira Kuwahara (A)

Department of Obstetrics and Gynecology, Institute of Health Biosciences, University of Tokushima School of Medicine, Tokushima 770-8503, Japan.

Minoru Irahara (M)

Department of Obstetrics and Gynecology, Institute of Health Biosciences, University of Tokushima School of Medicine, Tokushima 770-8503, Japan.

Akira Tokumura (A)

Department of Pharmaceutical Health Chemistry, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8505, Japan; Faculty of Pharmacy, Yasuda Women's University, Hiroshima 731-0153, Japan. Electronic address: tokumura@yasuda-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH